{
  "catalogId": "c2944527-dd61-4cf0-a254-1ff40bb330e2",
  "name": "XULTOPHY",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "155 72 34607 00",
  "treatmentDescriptions": "Xultophy® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control, and the population studied, see sections 4.4, 4.5 and 5.1",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "INSULIN DEGLUDEC 100 U/ML, LIRAGLUTIDE 3.6 MG/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "A10AE56",
      "name": "INSULIN DEGLUDEC AND LIRAGLUTIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "XULTOPHY 5X3ML PRE FILLED PEN",
      "manufacturer": {
        "name": "נובו נורדיסק",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 15.0,
        "unit": "units"
      },
      "packagingDescription": "PRE-FILLED PEN GLASS TYPE I",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "7886",
        "yarpa": "52675",
        "pharmasoft": "24092"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 645.1458866,
        "retailMargin": 17.5,
        "maxRetailPrice": 758.0464168,
        "maxPriceWithVAT": 894.494732
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:13.427534"
  }
}